Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16


Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.

Beretov J, Wasinger VC, Millar EK, Schwartz P, Graham PH, Li Y.

PLoS One. 2015 Nov 6;10(11):e0141876. doi: 10.1371/journal.pone.0141876. eCollection 2015.


Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies.

Gemoll T, Epping F, Heinrich L, Fritzsche B, Roblick UJ, Szymczak S, Hartwig S, Depping R, Bruch HP, Thorns C, Lehr S, Paech A, Habermann JK.

Oncotarget. 2015 Jun 30;6(18):16517-26.


Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology.

Ping Z, Siegal GP, Almeida JS, Schnitt SJ, Shen D.

J Pathol Inform. 2014 Jan 31;5:3. doi: 10.4103/2153-3539.126147. eCollection 2014.


Urine annexin A1 as an index for glomerular injury in patients.

Ka SM, Tsai PY, Chao TK, Yang SM, Hung YJ, Chen JS, Shui HA, Chen A.

Dis Markers. 2014;2014:854163. doi: 10.1155/2014/854163. Epub 2014 Jan 20.


Changes in proteomic profiles in different prostate lobes of male rats throughout growth and development and aging stages of the life span.

Das A, Bortner JD Jr, Aliaga CA, Baker A, Stanley A, Stanley BA, Kaag M, Richie JP Jr, El-Bayoumy K.

Prostate. 2013 Mar;73(4):363-75. doi: 10.1002/pros.22576. Epub 2012 Aug 21.


Clinical significance of annexin A1 expression in breast cancer.

Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI.

J Breast Cancer. 2011 Dec;14(4):262-8. doi: 10.4048/jbc.2011.14.4.262. Epub 2011 Dec 27.


Differential expression of anterior gradient gene AGR2 in prostate cancer.

Maresh EL, Mah V, Alavi M, Horvath S, Bagryanova L, Liebeskind ES, Knutzen LA, Zhou Y, Chia D, Liu AY, Goodglick L.

BMC Cancer. 2010 Dec 13;10:680. doi: 10.1186/1471-2407-10-680.


Higher levels of GATA3 predict better survival in women with breast cancer.

Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, Mah V, Bose S, Chia D, Chang HR, Goodglick L.

Hum Pathol. 2010 Dec;41(12):1794-801. doi: 10.1016/j.humpath.2010.06.010.


Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Fu M, Maresh EL, Soslow RA, Alavi M, Mah V, Zhou Q, Iasonos A, Goodglick L, Gordon LK, Braun J, Wadehra M.

Clin Cancer Res. 2010 Aug 1;16(15):3954-63. doi: 10.1158/1078-0432.CCR-10-0368.


Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast Cancer.

Lu M, Whitelegge JP, Whelan SA, He J, Saxton RE, Faull KF, Chang HR.

J Proteomics Bioinform. 2010 Jan 22;3(2):1-10.


Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.

Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, Grein J, Janatpour MJ.

Breast Cancer Res. 2010;12(3):R32. doi: 10.1186/bcr2586. Epub 2010 Jun 4.


Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications.

Tyburczy ME, Kotulska K, Pokarowski P, Mieczkowski J, Kucharska J, Grajkowska W, Roszkowski M, Jozwiak S, Kaminska B.

Am J Pathol. 2010 Apr;176(4):1878-90. doi: 10.2353/ajpath.2010.090950. Epub 2010 Feb 4.


Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration.

Lu QY, Yang Y, Jin YS, Zhang ZF, Heber D, Li FP, Dubinett SM, Sondej MA, Loo JA, Rao JY.

Proteomics. 2009 Feb;9(3):757-67. doi: 10.1002/pmic.200800019.


In silico gene expression analysis--an overview.

Murray D, Doran P, MacMathuna P, Moss AC.

Mol Cancer. 2007 Aug 7;6:50. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk